Clinico-epidemiological profile and treatment outcomes in patients with squamous cell carcinoma of the esophagus following docetaxel-based neoadjuvant chemotherapy: experience from a cancer care center in Northeast India

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
2589-0409
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
online resource.

Erschienen in
Clinico-epidemiological profile and treatment outcomes in patients with squamous cell carcinoma of the esophagus following docetaxel-based neoadjuvant chemotherapy: experience from a cancer care center in Northeast India ; volume:33 ; number:1 ; day:21 ; month:10 ; year:2021 ; pages:1-7 ; date:12.2021
Journal of the Egyptian National Cancer Institute / Egyptian National Cancer Institute ; 33, Heft 1 (21.10.2021), 1-7, 12.2021

Urheber
Roy, Partha Sarathi
Kumar, Gaurav
Mallik, Sreya
Sarangi, Satya Sadhan
Saikia, Bhargab Jyoti
Hazarika, Munlima
Talukdar, Abhijit
Beteiligte Personen und Organisationen
SpringerLink (Online service)

DOI
10.1186/s43046-021-00094-0
URN
urn:nbn:de:101:1-2022011420205668371073
Rechteinformation
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
15.08.2025, 07:35 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Roy, Partha Sarathi
  • Kumar, Gaurav
  • Mallik, Sreya
  • Sarangi, Satya Sadhan
  • Saikia, Bhargab Jyoti
  • Hazarika, Munlima
  • Talukdar, Abhijit
  • SpringerLink (Online service)

Ähnliche Objekte (12)

Significance of Neoadjuvant Downstaging in Carcinoma of Esophagus and Gastroesophageal Junction

Significance of Neoadjuvant Downstaging in Carcinoma of Esophagus and Gastroesophageal Junction

Neoadjuvant strategies in resectable carcinoma esophagus: a meta-analysis of randomized trials

Neoadjuvant strategies in resectable carcinoma esophagus: a meta-analysis of randomized trials

Neoadjuvant versus definitive chemoradiation in patients with squamous cell carcinoma of the esophagus

Neoadjuvant versus definitive chemoradiation in patients with squamous cell carcinoma of the esophagus

Expense and benefit of neoadjuvant treatment in squamous cell carcinoma of the esophagus

Expense and benefit of neoadjuvant treatment in squamous cell carcinoma of the esophagus

Esophagus

Online-Publikation | Zeitschrift

Esophagus

Clinico-immunological response to intratumoral versus intravenous neoadjuvant chemotherapy in advanced pediatric solid malignancies

Clinico-immunological response to intratumoral versus intravenous neoadjuvant chemotherapy in advanced pediatric solid malignancies

[Medico Clinico]

Kapitel

[Medico Clinico]

Ojo clínico

Abschnitt

Ojo clínico

Biomarker analysis of the NeoSphere study: pertuzumab, trastuzumab, and docetaxel versus trastuzumab plus docetaxel, pertuzumab plus trastuzumab, or pertuzumab plus docetaxel for the neoadjuvant treatment of HER2-positive breast cancer

Biomarker analysis of the NeoSphere study: pertuzumab, trastuzumab, and docetaxel versus trastuzumab plus docetaxel, pertuzumab plus trastuzumab, or pertuzumab plus docetaxel for the neoadjuvant treatment of HER2-positive breast cancer

Transcriptional expression of 8 genes predicts pathological response to first-line docetaxel + trastuzumab-based neoadjuvant chemotherapy

Transcriptional expression of 8 genes predicts pathological response to first-line docetaxel + trastuzumab-based neoadjuvant chemotherapy

Observationes clinico-practicae

Observationes clinico-practicae

Un caso clínico

Abschnitt

Un caso clínico

Verbundene Objekte